Navigation Links
Study finds taking probiotics has benefits for patients in hospitals
Date:6/4/2013

Patients in hospital who are on antibiotics may benefit from taking probiotics, according to researchers at St. Michaels Hospital.

Dr. Reena Pattani led a literature review that looked at the effectiveness of probiotics, live bacteria that can take up residence in digestive tracts, in treating common side effects of antibiotics, such as antibiotic-associated diarrhea and life-threatening side effects such as Clostridium difficile infection.

These two conditions are associated with high morbidity, mortality and health care costs, said Dr. Pattani, an internal medicine resident. Antibiotics are non-specific they target both our good and bad bacteria. And some of the good bacteria being killed off protect us from pathogens like C. difficle, a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the body.

Previous studies have shown 10 per cent of patients who receive antibiotics while in hospital will get antibiotic-associated diarrhea and of these patients, 15 per cent of them will have diarrhea because of C. difficle.

Dr. Pattani and colleagues scanned available literature for studies that compared patients who received probiotics and antibiotics at the same time in hospital, with patients who received antibiotics alone to see if rates of antibiotic-associated diarrhea and C. difficle infection were lower in those who also received probiotics.

They pooled the results of 16 studies, looking at data from 3,403 patients, and found a significant reduction in both antibiotic-associated diarrhea and C. difficle infection in patients who took probiotics with their antibiotics.

The results are likely due to the powerful effects of probiotics, including their ability to populate the digestive tract with healthy bacteria and strengthen the immune system, Dr. Pattani said.

Hospitalization is a key risk factor for acquiring C. difficle infection, Dr. Pattani said. Probiotics can help improve the health of individual patients by preventing C. difficle while also reducing the transmission of C. difficle to other, non-infected people in the high-risk inpatient environment. We hope these results will prompt physicians to consider its use.

Dr. Pattani said that while the results of her study are encouraging, a larger study including more patients, and one that looks at what kind of probiotics work best and at what doses needs to be done before hospital-wide policies can be made.

The paper appeared online in the journal Open Medicine today.

Dr. Pattani is a resident at the University of Toronto and St. Michaels incoming chief resident.


'/>"/>

Contact: Leslie Shepherd
shepherdl@smh.ca
416-864-6094
St. Michael's Hospital
Source:Eurekalert

Related biology news :

1. New study explains cognitive ability differences among the elderly
2. Oncologists are stressed and have difficulty discussing death with patients -- Ben-Gurion U. study
3. Stem cell study could aid quest to combat range of diseases
4. New study predicts rising irrigation costs, reduced yields for US corn
5. Circadian rhythms control bodys response to intestinal infections, UCI-led study finds
6. Study: Pedometer program helps motivate participants to sit less, move more
7. Thermal limit for animal life redefined by first lab study of deep-sea vent worms
8. Recovery of Hawaiian green sea turtles still short of historic levels, Stanford-led study suggests
9. Nordic diet lowers cholesterol, study finds
10. Study explores 100 year increase in forestry diseases
11. Reforestation study shows trade-offs between water, carbon and timber
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... DENVER , Jan. 23, 2017  The latest ... biometric smartphone prices have dropped dramatically. The quarterly average ... Q1 2013 to $276 in Q4 2016.  There are ... average price of $116, up from just 28 a ... According to Maxine Most , Acuity ...
(Date:1/19/2017)... Oregon and PUNE, India , January 19, 2017 ... Research, titled, "Global Biometric Sensor Market, Opportunities and Forecast, 2014 - 2022," ... growing at a CAGR of 9.6% from 2016 to 2022. In 2015, ... owing to high-level security for both public and private sectors. ... ...
(Date:1/18/2017)... Jan. 18, 2017  In vitro diagnostic (IVD) companies ... and acquisitions (M&A), and Kalorama Information expects that trend ... have been shifting. Generally, uncertainty in reimbursement and healthcare ... U.S. has changed the acquisitions landscape. Instead of looking ... companies buying partners outside of their home country and ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... 2017  If only one in every hundred ... resistance to chemotherapy, thousands of cancer cells would ... on finding these mutations in ever-smaller subpopulations of ... DNA in blood — to guide treatment decisions ... Unfortunately, however, detecting these genetic anomalies may be ...
(Date:2/16/2017)... (OTCMKTS: IMMG), an early-stage biotechnology company harnessing the power of ... negative breast cancer (TNBC), announced today their completion of the ... The YEi Start in France ... business in France and Europe.  ImMAGE ... an intensive one week immersion in France ...
(Date:2/16/2017)... 16, 2017   Capricor Therapeutics, Inc. ... company developing first-in-class biological therapies for cardiac and ... elected to terminate its license agreement with the ... including Cenderitide. "Our decision to return ... prioritize our efforts to advance our core cell ...
(Date:2/16/2017)... 2017  Champions Oncology, Inc. (NASDAQ: CSBR ... of advanced technology solutions and products to personalize the ... addition of new cohorts of PDX models to their ... expand Champions, product line in hepatocellular cancer, breast cancer, ... and non-small cell lung cancer (including EGFR mutation; ALK/ROS1 ...
Breaking Biology Technology: